Cas:5323-87-5 3-ethoxy-2-cyclohexen-1-one manufacturer & supplier

Chemical Name:3-ethoxy-2-cyclohexen-1-one

CAS.NO:5323-87-5

Synonyms:3-ethoxycyclohex-2-en-1-one;MFCD00001580;3-Ethoxy-2-cyclohexen-1-one;3-Ethoxycyclohex-2-enone;EINECS 226-190-7

Molecular Formula:C₈H₁₂O₂

Molecular Weight:140.18000

HS Code:2914509090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:76-78 °C (1 mmHg)

Density:1.04

Index of Refraction:1.503-1.505

PSA:26.30000

Exact Mass:140.08400

LogP:1.65980

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 3-ethoxycyclohex-2-en-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 226-190-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-ethoxycyclohex-2-en-1-one Use and application,3-Ethoxy-2-cyclohexen-1-one technical grade,usp/ep/jp grade.

Related News: In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. 3-ethoxy-2-cyclohexen-1-one manufacturer The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 3-ethoxy-2-cyclohexen-1-one supplier Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 3-ethoxy-2-cyclohexen-1-one vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 3-ethoxy-2-cyclohexen-1-one factory With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.